ОСОБЕННОСТИ ПОЛИМОРФИЗМА ГЕНОВ ИЛ-6 (IL-6-174G/C; IL-6-572G/C) У ПАЦИЕНТОВ РАЗЛИЧНЫХ ЭТНИЧЕСКИХ ГРУПП С ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА (ОБЗОР ЛИТЕРАТУРЫ)

Olga Valentinovna Smirnova, Vitaly Sergeevich Kablukov


Аннотация


Цель исследования. Представить читателю подробный обзор особенностей полиморфизма генов ИЛ-6 у пациентов различных этнических групп с ишемической болезнью сердца (ИБС), а также исследовать влияние разных генотипов однонуклеотидных полиморфизмов интерлейкина ИЛ-6 на циркуляционные уровни воспалительных и противовоспалительных цитокинов у пациентов с различными частотами аллелей с ИБС.

Материал и методы исследования. Авторами был проведён поиск литературы об особенностях полиморфизма генов ИЛ-6 у пациентов различных этнических групп с ИБС, с использованием соответствующих ключевых слов, в поисковых системах PubMed и Google Scholar, по базам данных Scopus, Web of Science, MedLine, The Cochrane Library, EMBASE, Global Health, CyberLeninka, РИНЦ и другим.

Результаты. Потенциальная связь между полиморфизмами генов ИЛ-6 и ИБС широко исследованы на сегодняшний день, однако результаты исследований остаются непоследовательными и несколько противоречивыми. Наиболее сильная взаимосвязь установлена по генотипам IL-6-174G/C; IL-6-572G/C для различных этнических групп, что и обуславливает интерес изучения в этом направлении в эпоху индивидуализации медицины.

Область применения результатов. Организация здравоохранения, кардиология, внутренние болезни, патологическая физиология.


Ключевые слова


ИЛ-6; полиморфизм генов; цитокиновая регуляция; ишемическая болезнь сердца; атеросклероз

Полный текст:

PDF>PDF

Литература


Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med, 1998, Vol. 340, pp. 115–126.

Shal’novas A., Evstifeevas. E., Deev A.D., Metel’skaya V.A., Kapustina A.V i drugie. Vklad markerov vospaleniya i IBS v obshchuyu i serdechno-sosudistuyu smertnost’ u pozhilyh zhitelej megapolisa (dannye issledovaniya SAHR) [Contribution of inflammation and ischemic heart disease markers to overall and cardiovascular mortality in the elderly population of the megalopolis (data of the SAHR study)]. Russ J Cardiol, 2015, №6 (122), рр. 7–13. DOI: http://dx.doi.org/10.15829/1560-4071-2015-06-7-13.

Kishimoto T. The biology of interleukin-6. Blood, 1989, Vol. 71, pp. 1–10.

Harris T.B., Ferrucci L., Tracy R.P. et al. Mortality risk associated with elevated interleukin-6 and C-reactive protein in old age. Am J Med, 1999, Vol. 106, pp. 506–512.

Kabłak-Ziembicka A., Przewłocki T., Stępień E., Pieniążek P. et al. Relationship between carotid intima-media thickness, cytokines, atherosclerosis extent and a two-year cardiovascular risk in patients with arteriosclerosis. Kardiol Pol, 2011, Vol. 69(10), pp. 1024–1031.

Tanindi A., Sahinarslan A., Elbeg S., Cemri M. Relationship Between MMP-1, MMP-9, TIMP-1, IL-6 and Risk Factors, Clinical Presentation, Extent and Severity of Atherosclerotic Coronary Artery Disease. Open Cardiovasc Med J, 2011, Vol. 5, pp. 110-116. doi: 10.2174/1874192401105010110.

Maitra A., Shanker J., Dash D., John S., Sannappa P.R., Rao V.S., et al. Polymorphisms in the IL6 gene in Asian Indian families with premature coronary artery disease--the Indian Atherosclerosis Research Study. Thromb Haemost, 2008, Vol. 99, pp. 944–950.

Brull D.J., Montgomery H.E., Sanders J., Dhamrait S., Luong L., Rumley A., et al. Interleukin-6 gene-174G/C and -572G/C promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol, 2001, Vol. 21, pp.1458–1463.

Isaac Subirana, Montserrat Fitó, Oscar Diaz, Joan Vila, Albert Francés, Eva Delpon, Juan Sanchis, Roberto Elosua, Daniel Muñoz-Aguayo, Irene R. Dégano&Jaume Marrugat. Prediction of coronary disease incidence by biomarkers of infammation, oxidation, and metabolism. Scientific Reports, 2018, Vol. 8, pp.3191. DOI:10.1038/s41598-018-21482-y.

Bernhard Schieffer; Tina Selle; Andres Hilfiker; Denise Hilfiker-Kleiner, et all. Impact of Interleukin-6 on Plaque Development and Morphology in Experimental Atherosclerosis. Circulation, 2004, Vol. 110, pp. 3493-3500. DOI:10.1161/01.CIR.0000148135.08582.97.

Mitrokhin V., Nikitin A., Brovkina O. et all. Association between interleukin-6/6R gene polymorphisms and coronary artery disease in Russian population: influence of interleukin-6/6R gene polymorphisms on inflammatory markers. Journal of Inflammation Research, 2017, Vol. 10, pp. 151–160.

Biasucci L.M., Vitelli A., Liuzzo G. Elevated levels of IL-6 in unstable angina. Circulation, 1996, Vol. 94, pp. 874–877.

de Maat M.P., Pietersma A., Kofflard M., Sluiter W., Kluft C. Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers. Atherosclerosis, 1996, Vol. 121, pp. 185–191.

Tappia P.S., Troughton K.L., Langley-Evans S.C., Grimble R.F. Cigarette smoking influences cytokine production and anti-oxidant defenses. Clin Sci, 1995, Vol. 88, pp. 485–489.

Northoff H., Weinstock C., Berg A. The cytokine response to strenuous exercise. Int J Sports Med, 1994, Vol. 15, pp. 167–171.

Zhou D., Kusnecov A.W., Shurin M.R., DePaoli M., Rabin B.S. Exposure to physical and psychological stressors elevates plasma interleukin-6: relationship to the activation of the hypothalamic-pituitary-adrenal axis. Endocrinology, 1993, Vol. 133, pp. 2523–2530.

Maes M., Song C., Lin A. et al. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine, 1998, Vol.10, pp. 313–318.

Song C., Kenis G., van Gastel A. et al. Influence of psychological stress on immune-inflammatory variables in normal humans. Part II. Altered serum concentrations of natural anti-inflammatory agents and soluble membrane antigens of monocytes and T lymphocytes. Psychiatry Res, 1999, Vol.85, pp. 293–303.

Riikola, A. et al. Interleukin-6 promoter polymorphism and cardiovascular risk factors: the Health 2000 Survey. Atherosclerosis, 2009, Vol. 207, №2, pp. 466–470.

Georges J.L., Loukaci V., Poirier O., Evans A., Luc G., Arveiler D. et al. Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Etude Cas-Témoin de l’Infarctus du Myocarde. J Mol Med Berl, 2001, Vol. 79(5-6), pp. 300–305.

Chiappelli M., Tampieri C., Tumini E., Porcellini E., Caldarera C.M., Nanni S. et al. Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men. Int J Immunogenet, 2005, Vol. 32(6), pp. 349–353.

Rios D.L., Cerqueira C.C., Bonfim-Silva R., Araújo L.J., Pereira J.F., Gadelha S.R. et al. Interleukin-1 beta and interleukin-6 gene polymorphism associations with angiographically assessed coronary artery disease in Brazilians. Cytokine, 2010, Vol. 50(3), pp. 292–296.

Niu W., Liu Y., Qi Y., Wu Z., Zhu D., Jin W. Association of interleukin-6 circulating levels with coronary artery disease: a meta-analysis implementing Mendelian randomization approach. Int J Cardiol, 2012, Vol. 157(2), pp. 243–252.

Phulukdaree A., Khan S., Ramkaran P., Govender R., Moodley D., Chuturgoon A.A. The interleukin-6 -147 g/c polymorphism is associated with increased risk of coronary artery disease in young South African Indian men. Metab Syndr Relat Disord, 2013, Vol. 11, pp. 205–209.

Humphries S.E., Luong L.A., Ogg M.S., Hawe E., Miller G.J. The interleukin-6 −174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J, 2001, Vol. 22(24), pp. 2243–2252.

Jenny N.S., Tracy R.P., Ogg M.S., le Luong A., Kuller L.H., Arnold A.M. et al. In the elderly, interleukin-6 plasma levels and the −174G > C polymorphism are associated with the development of cardiovascular disease. Arterioscler Thromb Vasc Biol, 2002, Vol, 22(12), pp. 2066–2071.

Rosner S.A., Ridker P.M., Zee R.Y., Cook N.R. Interaction between inflammation-related gene polymorphisms and cigarette smoking on the risk of myocardial infarction in the physician’s health study. Hum Genet, 2005, Vol. 118(2), pp. 287–294.

Nauck M., Winkelmann B.R., Hoffmann M.M., Böhm B.O., Wieland H., März W. The interleukin-6 G(−174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction. J Mol Med Berl, 2002, Vol. 80(8), pp. 507–513.

Kelberman D., Hawe E., Luong L.A., Mohamed-Ali V., Lundman P., Tornvall P. et al. Effect of Interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe. The HIFMECH Study. Thromb Haemost, 2004, Vol. 92(5), pp. 1122–1128.

Sie M.P., Sayed-Tabatabaei F.A., Oei H.H., Uitterlinden A.G., Pols H.A., Hofman A. et al. Interleukin 6–174 g/c promoter polymorphism and risk of coronary heart disease: results from the rotterdam study and a meta-analysis. Arterioscler Thromb Vasc Biol, 2006, Vol. 26(1), pp. 212–217.

Sekuri C., Cam F.S., Sagcan A., Ercan E., Tengiz I., Alioglu E., et al. No association of interleukin-6 gene polymorphism (-174 G/C) with premature coronary artery disease in a Turkish cohort. Coron Artery Dis, 2007, Vol. 18, pp. 333–337.

Lieb W., Pavlik R., Erdmann J., Mayer B., Holmer S.R., Fischer M. et al. No association of interleukin-6 gene polymorphism (-174 G/C) with myocardial infarction or traditional cardiovascular risk factors. Int J Cardiol, 2004, Vol. 97(2), pp. 205–212.

Ghazouani L., Ben Hadj Khalifa S., Abboud N., Ben Hamda K., Ben Khalfallah A., Brahim N. et al. TNF-alpha −308G > A and IL-6 −174G > C polymorphisms in Tunisian patients with coronary artery disease. Clin Biochem, 2010, Vol. 43(13–14), pp. 1085–1089.

Coker A., Arman A., Soylu O., Tezel T., Yildirim A. Lack of association between IL-1 and IL-6 gene polymorphisms and myocardial infarction in Turkish population. Int J Immunogenet, 2011, Vol. 38(3), pp. 201–208.

Hongmei Y., Yongping J., Jiyuan L. Interleukin-6 polymorphisms and risk of coronary artery diseases in a Chinese population: A casecontrol study. Pak J Med Sci, 2016, Vol. 32(4), pp. 880–885. doi: http://dx.doi.org/10.12669/pjms.324.9908.

Wei Y.S., Lan Y., Liu Y.G., Tang R.G., Lan J.S. Relationship between interleukin-6 gene polymorphism and coronary heart disease and its effect on plasma lipid levels. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 2006, Vol. 18(4), pp. 233–236.

Jia X., Tian Y., Wang Y., Deng X., Dong Z., Scafa N. et al. Association between the interleukin-6 gene −572G/C and −597G/A polymorphisms and coronary heart disease in the Han Chinese. Med Sci Monit, 2010, Vol. 16(3), pp.103–108.

Fragoso J.M., Delgadillo H., Juárez-Cedillo T., Rodríguez-Pérez J.M., Vallejo M., Pérez-Méndez O. et al. The interleukin 6–572 G > C (rs1800796) polymorphism is associated with the risk of developing acute coronary syndrome. Genet Test Mol Biomarkers, 2010, Vol. 14(6), pp. 759–763.

Fan W.H., Liu D.L., Xiao L.M., Xie C.J., Sun S.Y., Zhang J.C. Coronary heart disease and chronic periodontitis: is polymorphism of interleukin-6 gene the common risk factor in a Chinese population? Oral Dis, 2011, Vol. 17(3), pp. 270–276.

Ataç Çelik, Mustafa Özçetin, Ömer Ateş, Fatih Altunkaş, et al. Analyses of C-Reactive Protein, Endothelial Nitric Oxide Synthase and Interleukin-6 Gene Polymorphisms in Adolescents with a Family History of Premature Coronary Artery Disease: A Pilot Study. Balkan Medical Journal, 2015, Vol 32(4), pp. 397–402.

Fu H.X., Li G.S., Li Y., Xu J.L., Zhang J.Y. Interleukin-6 −597G/A and −572C/G polymorphisms and risk of coronary heart disease. Zhonghua Xin Xue Guan Bing Za Zhi, 2006, Vol. 34(6), pp. 519–522.

Humphries S.E., Luong L.A., Ogg M.S., Hawe E., Miller G.J. The interleukin-6 −174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J, 2001, Vol. 22(24), pp. 2243–2252.

Mälarstig A., Wallentin L., Siegbahn A. Genetic variation in the interleukin-6 gene in relation to risk and outcomes in acute coronary syndrome. Thromb Res, 2007, Vol. 119(4), pp. 467–473.

Banerjee I., Pandey U., Hasan O.M., Parihar R., Tripathi V., Ganesh S. Association between inflammatory gene polymorphisms and coronary artery disease in an Indian population. J Thromb Thrombolysis, 2009, Vol. 27(1), pp. 88–94.




DOI: https://doi.org/10.12731/wsd-2018-5-108-118

Ссылки

  • На текущий момент ссылки отсутствуют.




(c) 2018 Olga Valentinovna Smirnova, Vitaly Sergeevich Kablukov

Лицензия Creative Commons
Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial-NoDerivatives» («Атрибуция — Некоммерческое использование — Без производных произведений») 4.0 Всемирная.

ISSN 2072-0831 (print)

ISSN 2307-9428 (online)

Контент доступен под лицензией Creative Commons Attribution-NonCommercial-NoDerivs 4.0.

HotLog Яндекс цитирования